跳至主要内容
临床试验/NCT07686289
NCT07686289尚未招募不适用

A Controlled Evaluation of Optical Defocus Parameters on Transient Changes in Axial Length Using Kubota Glass

Kubota Vision Inc.0 个研究点目标入组 35 人开始时间: 2026年7月6日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
35
主要终点
Axial length

研究概览

简要总结

This study will assess the optimal performance characteristics of optical defocus on transient changes in axial length with Kubota Glass, using a randomized, double-masked, 5-treatment, 5-period crossover design with contralateral eye control.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
8 Years 至 24 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Be of legal age or, if under legal age have written consent of their parent or guardian to participate.
  • Sign written Informed Consent (and the California Bill of Rights, if applicable).
  • Be between age 8-24 (inclusive) and able to understand and assent to participation.
  • Have a spherical component of spectacle prescription between -1.00 and -5.00 diopters (D) (inclusive) in each eye.
  • Have a refractive astigmatism of less than or equal to -1.00 D in each eye.
  • Have axial length between 23.00 and 25.99 millimeters (mm) in each eye.
  • Best Spectacle Corrected Visual Acuity (BSCVA) of 20/25 or better in each eye.
  • Be willing and able to follow instructions and attend the schedule of follow-up visits.

排除标准

  • Unable or unwilling to provide informed consent and assent.
  • Eye injury or surgery within twelve weeks immediately prior to enrollment.
  • Currently enrolled in an ophthalmic clinical trial.
  • Pregnant or lactating or expect to become pregnant during the trial (by self-report).
  • Evidence of systemic or ocular abnormality, infection or disease.
  • Use of medications that may affect the eye (including, but not limited to, corticosteroids and antimetabolites).
  • Anisometropia ≥ 2.
  • Subjects who have undergone corneal refractive surgery.
  • Use atropine or other anticholinergic drug within the past month.
  • Employees or immediate family members of employees of study sites or sponsor.

结局指标

主要结局

Axial length

时间窗: 1 hour

次要结局

未报告次要终点

研究者

发起方
Kubota Vision Inc.
申办方类型
Industry
责任方
Sponsor

相似试验